Eydis Bio, Inc.
Durham, NC Eydis Bio, Inc.
- UEI
- MWWCM7JMBCF1
- CAGE
- 88U01
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 324 Blackwell St Suite 900, Durham, NC 27701, USA
- Website
- eydisbio.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Eydis Bio, Inc.
Eydis Bio, Inc. is a pharmaceutical research and development company focused on developing small molecule inhibitors targeting TAK1 (TGFβ-activated kinase 1) for various complex medical conditions, including neurodegenerative diseases, inflammatory disorders, and pain management. The company is registered in SAM.gov as a for-profit corporate entity located in Durham, North Carolina, with a current registration valid through November 2, 2025. Through its federal contract and grant awards, Eydis Bio, Inc. provides specialized pharmaceutical research services, particularly around the development and screening of novel molecular compounds targeting specific kinase pathways for potential therapeutic interventions.
The company has received one federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Small Business Innovation Research (SBIR) program. The $499,825 firm-fixed-price contract focuses on performing a structure-activity relationship (SAR) analysis, molecular binding, and metabolism studies of a lead scaffold (HS-176) to guide the development of more potent and drug-like analog compounds. This contract is set aside specifically for small businesses and aims to support the company's research into developing more effective pharmaceutical compounds.
Eydis Bio, Inc. has been awarded multiple federal grants from various National Institutes of Health (NIH) institutes, targeting different medical conditions through TAK1 inhibitor research. These grants include a project from the National Institute on Aging for developing orally bioavailable TAK1 inhibitors as a potential Alzheimer's disease treatment, a grant from the National Heart Lung and Blood Institute for developing compounds to treat systemic sclerosis-associated interstitial lung disease, another from the National Institute of Arthritis and Musculoskeletal and Skin Diseases for rheumatoid arthritis treatment, a grant from the National Institute of Neurological Disorders and Stroke targeting chronic pain, and a COVID-19 related research grant from the National Heart Lung and Blood Institute. Each grant involves preclinical development and research into potential therapeutic applications of TAK1 inhibitors across various disease states, often conducted in collaboration with academic research partners like North Carolina State University.
Quick answers
What is Eydis Bio, Inc.'s UEI?
Eydis Bio, Inc.'s Unique Entity ID (UEI) in SAM.gov is MWWCM7JMBCF1.
What is Eydis Bio, Inc.'s CAGE code?
Eydis Bio, Inc.'s CAGE code is 88U01.
What is Eydis Bio, Inc.'s primary NAICS code?
Eydis Bio, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Eydis Bio, Inc. located?
Eydis Bio, Inc.'s physical address in SAM.gov is 324 Blackwell St Suite 900, Durham, NC 27701, USA.
Is Eydis Bio, Inc. registered in SAM.gov?
Yes. Eydis Bio, Inc.'s SAM.gov registration is active through April 13, 2027.
What is Eydis Bio, Inc.'s most recent federal award?
Eydis Bio, Inc.'s most recent federal contract award is Perform a structure activity relationship (SAR), molecular binding and metabolism of the lead scaffold (HS-176) to guide… (75N93025C00040), from National Institute of Allergy and Infectious Diseases, on September 29, 2025.
On GovTribe
See Eydis Bio, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors